Should We Measure C-reactive Protein on Earth or Just on JUPITER?

被引：17

作者：

Bajpai, Ambareesh ^{[1
]}

Goyal, Abhinav ^{[1
]}

Sperling, Laurence ^{[1
]}

机构：

[1] Emory Univ, Dept Cardiol, Atlanta, GA 30322 USA

来源：

CLINICAL CARDIOLOGY | 2010年 / 33卷 / 04期

关键词：

CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK PREDICTION; MIDDLE-AGED MEN; FIBRIN D-DIMER; INFLAMMATORY MARKERS; RANDOMIZED-TRIAL; STATIN THERAPY; WOMEN; MORTALITY; INTERLEUKIN-6;

D O I：

10.1002/clc.20681

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Evidence for the role of inflammation in the pathogenesis of atherosclerosis is compelling and has generated interest in high-sensitivity C-reactive protein (hs-CRP) as a marker of cardiovascular risk. Data regarding hs-CRP and cardiovascular risk, though largely consistent, is of unclear clinical relevance. Most recently, the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has led to further debate regarding the utility of hs-CRP. This article provides a comprehensive review of the data regarding cardiovascular risk and hs-CRP with an emphasis on the JUPITER trial and concludes with an evidence-based analysis of the current role of hs-CRP in cardiovascular risk assessment.

引用

收藏

页码：190 / 198

页数：9

相关论文

共 49 条

[1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[2] Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].

Ballantyne, CM ;

Hoogeveen, RC ;

Bang, H ;

Coresh, J ;

Folsom, AR ;

Heiss, G ;

Sharrett, AR .

CIRCULATION, 2004, 109 (07) :837-842

[3] Possible protective role for c-reactive protein in atherogenesis - Complement activation by modified lipoproteins halts before detrimental terminal sequence [J].

Bhakdi, S ;

Torzewski, M ;

Paprotka, K ;

Schmitt, S ;

Barsoom, H ;

Suriyaphol, P ;

Han, SR ;

Lackner, KJ ;

Husmann, M .

CIRCULATION, 2004, 109 (15) :1870-1876

[4] Fluctuating inflammatory markers in patients with stable ischemic heart disease [J].

Bogaty, P ;

Brophy, MM ;

Boyer, L ;

Simard, S ;

Joseph, L ;

Bertrand, F ;

Dagenais, GR .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) :221-226

[5] C-reactive protein and coronary heart disease: a critical review [J].

Casas, J. P. ;

Shah, T. ;

Hingorani, A. D. ;

Danesh, J. ;

Pepys, M. B. .

JOURNAL OF INTERNAL MEDICINE, 2008, 264 (04) :295-314

[6] Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study [J].

Cesari, M ;

Penninx, BWJH ;

Newman, AB ;

Kritchevsky, SB ;

Nicklas, BJ ;

Sutton-Tyrrell, K ;

Rubin, SM ;

Ding, JZ ;

Simonsick, EM ;

Harris, TB ;

Pahor, M .

CIRCULATION, 2003, 108 (19) :2317-2322

[7] C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids [J].

Chang, MK ;

Binder, CJ ;

Torzewski, M ;

Witztum, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13043-13048

[8] The effect of including C-reactive protein in cardiovascular risk prediction models for women [J].

Cook, Nancy R. ;

Buring, Julie E. ;

Ridker, Paul M. .

ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) :21-29

[9] C-reactive protein and the 10-year incidence of coronary heart disease in older men and women - The cardiovascular health study [J].

Cushman, M ;

Arnold, AM ;

Psaty, BM ;

Manolio, TA ;

Kuller, LH ;

Burke, GL ;

Polak, JF ;

Tracy, RP .

CIRCULATION, 2005, 112 (01) :25-31

[10] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].

Danesh, J ;

Whincup, P ;

Walker, M ;

Lennon, L ;

Thomson, A ;

Appleby, P ;

Gallimore, JR ;

Pepys, MB .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204

← 1 2 3 4 5 →